Chengming Zhu

sun yat-sen university

H指数:31

被引数:6,299

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

DYNLT1–TP53BP2 axis drives tamoxifen resistance in breast cancer by activating PI3K/Akt/mTOR signaling

DYNLT1–TP53BP2轴通过激活PI3K/Akt/mTOR信号通路驱动乳腺癌对他莫昔芬的耐药性

Life Sciences

IF5.1

2026-09-220

PRE

Proteomic screening of TMEM43 binding partners identifies VDAC leading to mitochondrial dysfunction

TMEM43结合蛋白的蛋白质组学筛选鉴定出VDAC，导致线粒体功能障碍

PLoS One

IF2.6

2025-12-180

PRE

The tumor suppressor SALL2 opposes chemotherapeutic resistance in breast cancer

MOLECULAR AND CELLULAR BIOCHEMISTRY

IF3.7

2024-11-220

OAAI

RNA-binding protein LSM7 facilitates breast cancer metastasis through mediating alternative splicing of CD44

RNA结合蛋白LSM7通过介导CD44的选择性剪接促进乳腺癌转移

LIFE SCIENCES

IF5.1

2024-11-011

OAAI

RANKL/RANK signaling recruits Tregs via the CCL20-CCR6 pathway and promotes stemness and metastasis in colorectal cancer

CELL DEATH & DISEASE

IF9.6

2024-06-202

OAAI

Insufficient phosphorylation of STAT5 in Tregs inhibits the expression of BLIMP-1 but not IRF4, reduction the proportion of Tregs in pediatric aplastic anemia

HELIYON

IF3.6

2024-03-011

OAAI

Mutation spectrum of homologous recombination repair genes in early triple-negative breast cancer: association with clinicopathological factors, immune infiltration, and prognosis

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-03-010

PRE

Enhancement of PRMT6 binding to a novel germline GATA1 mutation associated with congenital anemia

HAEMATOLOGICA

IF7.9

2024-02-221

OAAI

LILRB1+immune cell infiltration identifies immunosuppressive microenvironment and dismal outcomes of patients with ovarian cancer

LILRB1免疫细胞浸润可识别卵巢癌患者的免疫抑制微环境和不良结局

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2023-06-016

PRE

Immune desert in MMR-deficient tumors predicts poor responsiveness of immune checkpoint inhibition

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-04-284

OAAI

Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers

间叶性胃肠道癌的免疫学和免疫治疗进展

MOLECULAR CANCER

IF33.9

2023-04-1820

OAAI

Early embryonic lethality due to targeted inactivation of DNA ligase III

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-27122

OAAI

Snm1-deficient mice exhibit accelerated tumorigenesis and susceptibility to infection

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-2734

OAAI

Causal Inference of Central Nervous System-Regulated Hormones in COVID-19: A Bidirectional Two-Sample Mendelian Randomization Study

JOURNAL OF CLINICAL MEDICINE

IF2.9

2023-02-202

OAAI

BMAL1 collaborates with CLOCK to directly promote DNA double-strand break repair and tumor chemoresistance

ONCOGENE

IF7.3

2023-02-0210

OAAI

Extra cup of tea intake associated with increased risk of Alzheimer's disease: Genetic insights from Mendelian randomization

FRONTIERS IN NUTRITION

IF5.1

2023-01-2510

OAAI

Tyrosine kinase SRC-induced YAP1-KLF5 module regulates cancer stemness and metastasis in triple-negative breast cancer

酪氨酸激酶SRC诱导的YAP1-KLF5模块调节三阴性乳腺癌的癌症stemness和转移

CELLULAR AND MOLECULAR LIFE SCIENCES

IF6.2

2023-01-1214

OAAI

SRC kinase-mediated signaling pathways and targeted therapies in breast cancer

BREAST CANCER RESEARCH

IF5.6

2022-12-2943

OAAI

Comprehensive Analysis of the Expression and Prognostic Value of LMAN2 in HER2+Breast Cancer

JOURNAL OF IMMUNOLOGY RESEARCH

IF3.6

2022-06-069

OAAI

Aberrantly expressed Wnt5a in nurse-like cells drives resistance to Venetoclax in chronic lymphocytic leukemia

CELL DEATH DISCOVERY

IF7

2022-02-2414

OAAI

Chengming Zhu

个人简介

教育背景

工作经历

荣誉奖项

研究方向